Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?

M. R. Macleod; G. A. Donnan

doi:10.1586/14779072.1.4.487

Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?

M. R. Macleod^*, G. A. Donnan

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

Abstract / Description of output

Atheroma of the aortic arch is an important risk factor for stroke and for recurrent stroke. Optimal management is not known but these patients should probably receive more powerful antiplatelet treatment than aspirin alone. Whether combination treatment with aspirin plus clopidogrel is more effective than warfarin alone is the subject of the ongoing ARCH study.

Original language	English
Pages (from-to)	487-489
Number of pages	3
Journal	Expert Review of Cardiovascular Therapy
Volume	1
Issue number	4
DOIs	https://doi.org/10.1586/14779072.1.4.487
Publication status	Published - Nov 2003

Access to Document

10.1586/14779072.1.4.487

Cite this

@article{70d8ae3c66a849c68bc3c0905cad7e54,

title = "Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?",

abstract = "Atheroma of the aortic arch is an important risk factor for stroke and for recurrent stroke. Optimal management is not known but these patients should probably receive more powerful antiplatelet treatment than aspirin alone. Whether combination treatment with aspirin plus clopidogrel is more effective than warfarin alone is the subject of the ongoing ARCH study.",

author = "Macleod, {M. R.} and Donnan, {G. A.}",

year = "2003",

month = nov,

doi = "10.1586/14779072.1.4.487",

language = "English",

volume = "1",

pages = "487--489",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",

publisher = "Expert Reviews Ltd.",

number = "4",

}

TY - JOUR

T1 - Atheroma of the aortic arch

T2 - the missing link in the secondary prevention of stroke?

AU - Macleod, M. R.

AU - Donnan, G. A.

PY - 2003/11

Y1 - 2003/11

N2 - Atheroma of the aortic arch is an important risk factor for stroke and for recurrent stroke. Optimal management is not known but these patients should probably receive more powerful antiplatelet treatment than aspirin alone. Whether combination treatment with aspirin plus clopidogrel is more effective than warfarin alone is the subject of the ongoing ARCH study.

AB - Atheroma of the aortic arch is an important risk factor for stroke and for recurrent stroke. Optimal management is not known but these patients should probably receive more powerful antiplatelet treatment than aspirin alone. Whether combination treatment with aspirin plus clopidogrel is more effective than warfarin alone is the subject of the ongoing ARCH study.

UR - http://www.scopus.com/inward/record.url?scp=2942734278&partnerID=8YFLogxK

U2 - 10.1586/14779072.1.4.487

DO - 10.1586/14779072.1.4.487

M3 - Editorial

C2 - 15030247

AN - SCOPUS:2942734278

SN - 1477-9072

VL - 1

SP - 487

EP - 489

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

IS - 4

ER -

Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?

Abstract / Description of output

Access to Document

Other files and links

Fingerprint

Cite this